SWKS
58
10
EMC
73
12
SYK
60
5
DUK
52
-3
IRM
55
3
TRIP
67
-9
COST
54
3
DLTR
62
6
PM
72
-5
FE
64
-2
ICE
64
-7
PNR
80
9
ACN
59
7
CHRW
71
14
VFC
67
8
CMS
57
-11
WFC
83
6
WDC
68
5
HPQ
73
10
LMT
62
2
SWKS
58
10
EMC
73
12
SYK
60
5
DUK
52
-3
IRM
55
3
TRIP
67
-9
COST
54
3
DLTR
62
6
PM
72
-5
FE
64
-2
ICE
64
-7
PNR
80
9
ACN
59
7
CHRW
71
14
VFC
67
8
CMS
57
-11
WFC
83
6
WDC
68
5
HPQ
73
10
LMT
62
2
Financhill
Back

Bicara Therapeutics Vs. Charles River Laboratories International Industry Stock Comparison

Buy
58

BCAX
Bicara Therapeutics

Last Price:
$13.06
Seasonality Move:
--
Buy
59

CRL
Charles River Laboratories International

Last Price:
$143.16
Seasonality Move:
7.09%
Buy
58
Bicara Therapeutics (BCAX) is a Buy

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $14.19. The Score for BCAX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Charles River Laboratories International (CRL) is a Buy

Is Charles River Laboratories International a Buy, Sell or Hold?

  • The current Charles River Laboratories International [CRL] share price is $143.08. The Score for CRL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $14.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRL Stock Price Chart

What is Charles River Laboratories International's stock price today?

  • The Charles River Laboratories International share price today is $143.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing slight selling pressure.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 55.19 Buy
Chaikin Money Flow: 315501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11 - 14.7) Buy
Bollinger Bands (100): (11.57 - 15.81) Buy

CRL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.93 Buy
Relative Strength Index (14 RSI): 62.18 Buy
Chaikin Money Flow: -450378 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.66 - 131.32) Buy
Bollinger Bands (100): (130.85 - 182.43) Sell

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.51 Buy
20-day SMA: 13.55 Buy
50-day SMA: 13.08 Buy
200-day SMA: 0 Buy
8-day EMA: 13.5 Buy
20-day EMA: 13.38 Buy
50-day EMA: 13.28 Buy
200-day EMA: 11.72 Buy

CRL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.8 Buy
20-day SMA: 117.66 Buy
50-day SMA: 140.26 Buy
200-day SMA: 178.62 Sell
8-day EMA: 131.69 Buy
20-day EMA: 122.29 Buy
50-day EMA: 97.4 Buy
200-day EMA: 39.8 Buy

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.00 per share, and a decrease next year of $0.52 per share.

Charles River Laboratories International Earnings Growth & CRL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.58 per share, and an increase next year of $0.66 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Charles River Laboratories International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):